Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension

Hiroshi Itoh, Katsuhisa Ishii, Hajime Kihara, Noriaki Kasayuki, Fumiaki Nakamura, Kenei Shimada, Shota Fukuda, Katsuomi Iwakura, Junichi Yoshikawa

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Hypertension is associated with an increased risk of diastolic dysfunction. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) have failed to show improvement in clinical outcomes for patients with diastolic dysfunction. In this study, we investigated the effect of changing an ACEi or ARB to a combination of losartan and hydrochlorothiazide (HCTZ) on left ventricular (LV) preload and relaxation in patients with hypertension and diastolic dysfunction. We enrolled 371 hypertensive patients with diastolic dysfunction who had not achieved their treatment goals with an ACEi or ARB. We switched the ACEi or ARB to losartan/HCTZ and followed the patients for 24 weeks. The primary end points were changes in septal mitral annular velocity during diastole (e′) and in the ratio of mitral inflow velocity to e′ velocity (E/e′ ratio) from baseline to the end of follow-up. Mean systolic and diastolic blood pressures (BP) decreased by 22 and 11 mm Hg, respectively, after changing from an ACEi or ARB to losartan/HCTZ. The e′ velocity increased, and the E/e′ ratio and brain natriuretic peptide level decreased significantly. High-sensitivity C-reactive protein also decreased significantly (0.50 vs. 0.29 mg dl -1, P

Original languageEnglish
Pages (from-to)93-99
Number of pages7
JournalHypertension Research
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Thiazides
Angiotensin Receptor Antagonists
Angiotensins
Angiotensin-Converting Enzyme Inhibitors
Renin
Heart Failure
Hypertension
Blood Pressure
Diastole
Brain Natriuretic Peptide
C-Reactive Protein
losartan drug combination hydrochlorothiazide

Keywords

  • diastolic function
  • echocardiography
  • heart failure
  • hemodynamics

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension. / Itoh, Hiroshi; Ishii, Katsuhisa; Kihara, Hajime; Kasayuki, Noriaki; Nakamura, Fumiaki; Shimada, Kenei; Fukuda, Shota; Iwakura, Katsuomi; Yoshikawa, Junichi.

In: Hypertension Research, Vol. 35, No. 1, 01.2012, p. 93-99.

Research output: Contribution to journalArticle

Itoh, H, Ishii, K, Kihara, H, Kasayuki, N, Nakamura, F, Shimada, K, Fukuda, S, Iwakura, K & Yoshikawa, J 2012, 'Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension', Hypertension Research, vol. 35, no. 1, pp. 93-99. https://doi.org/10.1038/hr.2011.169
Itoh, Hiroshi ; Ishii, Katsuhisa ; Kihara, Hajime ; Kasayuki, Noriaki ; Nakamura, Fumiaki ; Shimada, Kenei ; Fukuda, Shota ; Iwakura, Katsuomi ; Yoshikawa, Junichi. / Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension. In: Hypertension Research. 2012 ; Vol. 35, No. 1. pp. 93-99.
@article{b211b6fb55a44b28820a05ee0e23c9a2,
title = "Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension",
abstract = "Hypertension is associated with an increased risk of diastolic dysfunction. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) have failed to show improvement in clinical outcomes for patients with diastolic dysfunction. In this study, we investigated the effect of changing an ACEi or ARB to a combination of losartan and hydrochlorothiazide (HCTZ) on left ventricular (LV) preload and relaxation in patients with hypertension and diastolic dysfunction. We enrolled 371 hypertensive patients with diastolic dysfunction who had not achieved their treatment goals with an ACEi or ARB. We switched the ACEi or ARB to losartan/HCTZ and followed the patients for 24 weeks. The primary end points were changes in septal mitral annular velocity during diastole (e′) and in the ratio of mitral inflow velocity to e′ velocity (E/e′ ratio) from baseline to the end of follow-up. Mean systolic and diastolic blood pressures (BP) decreased by 22 and 11 mm Hg, respectively, after changing from an ACEi or ARB to losartan/HCTZ. The e′ velocity increased, and the E/e′ ratio and brain natriuretic peptide level decreased significantly. High-sensitivity C-reactive protein also decreased significantly (0.50 vs. 0.29 mg dl -1, P",
keywords = "diastolic function, echocardiography, heart failure, hemodynamics",
author = "Hiroshi Itoh and Katsuhisa Ishii and Hajime Kihara and Noriaki Kasayuki and Fumiaki Nakamura and Kenei Shimada and Shota Fukuda and Katsuomi Iwakura and Junichi Yoshikawa",
year = "2012",
month = "1",
doi = "10.1038/hr.2011.169",
language = "English",
volume = "35",
pages = "93--99",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension

AU - Itoh, Hiroshi

AU - Ishii, Katsuhisa

AU - Kihara, Hajime

AU - Kasayuki, Noriaki

AU - Nakamura, Fumiaki

AU - Shimada, Kenei

AU - Fukuda, Shota

AU - Iwakura, Katsuomi

AU - Yoshikawa, Junichi

PY - 2012/1

Y1 - 2012/1

N2 - Hypertension is associated with an increased risk of diastolic dysfunction. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) have failed to show improvement in clinical outcomes for patients with diastolic dysfunction. In this study, we investigated the effect of changing an ACEi or ARB to a combination of losartan and hydrochlorothiazide (HCTZ) on left ventricular (LV) preload and relaxation in patients with hypertension and diastolic dysfunction. We enrolled 371 hypertensive patients with diastolic dysfunction who had not achieved their treatment goals with an ACEi or ARB. We switched the ACEi or ARB to losartan/HCTZ and followed the patients for 24 weeks. The primary end points were changes in septal mitral annular velocity during diastole (e′) and in the ratio of mitral inflow velocity to e′ velocity (E/e′ ratio) from baseline to the end of follow-up. Mean systolic and diastolic blood pressures (BP) decreased by 22 and 11 mm Hg, respectively, after changing from an ACEi or ARB to losartan/HCTZ. The e′ velocity increased, and the E/e′ ratio and brain natriuretic peptide level decreased significantly. High-sensitivity C-reactive protein also decreased significantly (0.50 vs. 0.29 mg dl -1, P

AB - Hypertension is associated with an increased risk of diastolic dysfunction. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) have failed to show improvement in clinical outcomes for patients with diastolic dysfunction. In this study, we investigated the effect of changing an ACEi or ARB to a combination of losartan and hydrochlorothiazide (HCTZ) on left ventricular (LV) preload and relaxation in patients with hypertension and diastolic dysfunction. We enrolled 371 hypertensive patients with diastolic dysfunction who had not achieved their treatment goals with an ACEi or ARB. We switched the ACEi or ARB to losartan/HCTZ and followed the patients for 24 weeks. The primary end points were changes in septal mitral annular velocity during diastole (e′) and in the ratio of mitral inflow velocity to e′ velocity (E/e′ ratio) from baseline to the end of follow-up. Mean systolic and diastolic blood pressures (BP) decreased by 22 and 11 mm Hg, respectively, after changing from an ACEi or ARB to losartan/HCTZ. The e′ velocity increased, and the E/e′ ratio and brain natriuretic peptide level decreased significantly. High-sensitivity C-reactive protein also decreased significantly (0.50 vs. 0.29 mg dl -1, P

KW - diastolic function

KW - echocardiography

KW - heart failure

KW - hemodynamics

UR - http://www.scopus.com/inward/record.url?scp=84855466040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855466040&partnerID=8YFLogxK

U2 - 10.1038/hr.2011.169

DO - 10.1038/hr.2011.169

M3 - Article

C2 - 22011686

AN - SCOPUS:84855466040

VL - 35

SP - 93

EP - 99

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 1

ER -